New EU Filings
A Regularly Updated List Of New Marketing Authorization Applications At The EMA
BioMarin Pharmaceutical's investigational gene therapy, Roctavian (valoctocogene roxaparvovec), for treating adults with severe hemophilia A is among the latest new medicines that have been submitted for pan-EU approval.